JP2005538089A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538089A5
JP2005538089A5 JP2004522648A JP2004522648A JP2005538089A5 JP 2005538089 A5 JP2005538089 A5 JP 2005538089A5 JP 2004522648 A JP2004522648 A JP 2004522648A JP 2004522648 A JP2004522648 A JP 2004522648A JP 2005538089 A5 JP2005538089 A5 JP 2005538089A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
methyl
acid addition
addition salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004522648A
Other languages
English (en)
Japanese (ja)
Other versions
JP4656939B2 (ja
JP2005538089A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2003/003349 external-priority patent/WO2004009086A1/en
Publication of JP2005538089A publication Critical patent/JP2005538089A/ja
Publication of JP2005538089A5 publication Critical patent/JP2005538089A5/ja
Application granted granted Critical
Publication of JP4656939B2 publication Critical patent/JP4656939B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004522648A 2002-07-22 2003-07-16 フェニルスルホニル基を含む選択的エストロゲン受容体モジュレーター Expired - Fee Related JP4656939B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39786902P 2002-07-22 2002-07-22
US45023303P 2003-02-25 2003-02-25
PCT/IB2003/003349 WO2004009086A1 (en) 2002-07-22 2003-07-16 Selective estrogen receptor modulators containing a phenylsulfonyl group

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010109009A Division JP5220800B2 (ja) 2002-07-22 2010-05-11 フェニルスルホニル基を含む選択的エストロゲン受容体モジュレーター

Publications (3)

Publication Number Publication Date
JP2005538089A JP2005538089A (ja) 2005-12-15
JP2005538089A5 true JP2005538089A5 (enExample) 2007-08-16
JP4656939B2 JP4656939B2 (ja) 2011-03-23

Family

ID=30773044

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004522648A Expired - Fee Related JP4656939B2 (ja) 2002-07-22 2003-07-16 フェニルスルホニル基を含む選択的エストロゲン受容体モジュレーター
JP2010109009A Expired - Fee Related JP5220800B2 (ja) 2002-07-22 2010-05-11 フェニルスルホニル基を含む選択的エストロゲン受容体モジュレーター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010109009A Expired - Fee Related JP5220800B2 (ja) 2002-07-22 2010-05-11 フェニルスルホニル基を含む選択的エストロゲン受容体モジュレーター

Country Status (24)

Country Link
US (2) US7399867B2 (enExample)
EP (1) EP1530470B9 (enExample)
JP (2) JP4656939B2 (enExample)
CN (1) CN1668303B (enExample)
AT (1) ATE433322T1 (enExample)
AU (1) AU2003253129B2 (enExample)
BR (1) BR0312675A (enExample)
CA (1) CA2490580C (enExample)
CO (1) CO5680445A2 (enExample)
CR (1) CR7657A (enExample)
DE (1) DE60327931D1 (enExample)
EA (1) EA008024B1 (enExample)
EC (1) ECSP055549A (enExample)
ES (1) ES2326593T3 (enExample)
HR (1) HRP20041233A2 (enExample)
IL (1) IL165745A0 (enExample)
MX (1) MXPA05000898A (enExample)
MY (1) MY141879A (enExample)
NO (1) NO20050832L (enExample)
NZ (1) NZ537138A (enExample)
PE (1) PE20040678A1 (enExample)
PL (1) PL374845A1 (enExample)
TW (1) TWI314860B (enExample)
WO (1) WO2004009086A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL374845A1 (en) * 2002-07-22 2005-11-14 Eli Lilly And Company Selective estrogen receptor modulators containing a phenylsulfonyl group
EA007978B1 (ru) * 2003-02-25 2007-02-27 Эли Лилли Энд Компани Кристаллический несольватированный гидрохлорид 1-(4-(2-пиперидинилэтокси)фенокси)-2-(4-метансульфонилфенил)-6-гидроксинафталина
HRP20050675A2 (en) * 2003-02-25 2005-10-31 Eli Lilly And Company Crystalline non-solavated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
ATE448215T1 (de) * 2004-01-22 2009-11-15 Lilly Co Eli Selektive östrogen-rezeptor-modulatoren
CN1910167B (zh) * 2004-01-22 2011-08-10 伊莱利利公司 用于治疗血管舒缩症状的选择性雌激素受体调节剂
EA012262B1 (ru) 2004-01-22 2009-08-28 Эли Лилли Энд Компани Селективные модуляторы рецепторов эстрогена для лечения вазомоторных симптомов
WO2005073190A1 (en) * 2004-01-29 2005-08-11 Eli Lilly And Company Selective estrogen receptor modulators
MXPA06015152A (es) 2004-06-22 2007-02-28 Smithkline Beecham Corp Compuestos quimicos.
WO2007016139A2 (en) * 2005-07-29 2007-02-08 Eli Lilly And Company Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene
MX2011003383A (es) * 2008-09-29 2011-04-21 Lilly Co Eli Modulador selectivo del receptor de estrogeno para el tratamiento de osteoartritis.
DE102008057230A1 (de) 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
EP2406230A1 (en) 2009-03-11 2012-01-18 Pfizer Inc. Substituted indazole amides and their use as glucokinase activators
SG186333A1 (en) 2010-06-16 2013-01-30 Endorech Inc Methods of treating or preventing estrogen-related diseases
JP6292744B2 (ja) * 2012-09-19 2018-03-14 富士カプセル株式会社 医薬品組成物
NZ710385A (en) 2013-02-19 2016-10-28 Novartis Ag Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
WO2020182649A1 (en) 2019-03-08 2020-09-17 Syngenta Crop Protection Ag Pesticidally active azole-amide compounds
US20220183294A1 (en) 2019-03-20 2022-06-16 Syngenta Crop Protection Ag Pesticidally active azole amide compounds
US20220213063A1 (en) 2019-03-22 2022-07-07 Syngenta Crop Protection Ag N-[l-(5-BROMO-2-PYRIMIDIN-2-YL-1,2,4-TRIAZOL-3-YL)ETHYL]-2-CYCLOPROPYL-6-(TRIFLUOROMETHYL)PYRIDINE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INSECTICIDES
TWI853009B (zh) 2019-03-29 2024-08-21 瑞士商先正達農作物保護公司 殺有害生物活性之二-醯胺化合物
WO2020201398A1 (en) 2019-04-05 2020-10-08 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
JP2022545266A (ja) 2019-08-23 2022-10-26 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 殺有害生物的に活性なピラジン-アミド化合物
CN110526881B (zh) * 2019-08-27 2020-09-22 河南省锐达医药科技有限公司 一种萘胺类化合物及其生物学可接受的盐,其制备方法和应用
WO2021170881A1 (en) 2020-02-27 2021-09-02 Syngenta Crop Protection Ag Pesticidally active diazine-bisamide compounds
JP2024518832A (ja) * 2021-05-14 2024-05-07 江▲蘇▼▲亞▼虹医▲薬▼科技股▲フン▼有限公司 ナフタレン環含有化合物、それを含む医薬組成物及びその使用
BR112023025644A2 (pt) 2021-06-09 2024-02-27 Syngenta Crop Protection Ag Compostos de diazina-amida pesticidamente ativos
WO2023283315A1 (en) * 2021-07-07 2023-01-12 South Dakota Board Of Regents Compositions and methods for treatment of cervical and ovarian cancer
JP2025526986A (ja) 2022-08-25 2025-08-15 サノフイ 新規な置換ベンゾチオフェン-6-カルボン酸誘導体、その調製方法、及びその治療的使用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
WO1993023374A1 (fr) 1992-05-08 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Derive d'indole
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US7501441B1 (en) * 1994-09-20 2009-03-10 Eli Lilly And Company Naphthyl compounds, intermediates, processes, compositions, and methods
US6399634B1 (en) 1994-09-20 2002-06-04 Eli Lilly And Company Benzothiophene compounds, compositions, and methods
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
JP3989569B2 (ja) 1995-02-28 2007-10-10 イーライ リリー アンド カンパニー ベンゾチオフェン化合物、中間体、組成物および方法
US5599822A (en) 1995-06-06 1997-02-04 Eli Lilly And Company Methods for minimizing bone loss
JP2002500618A (ja) * 1995-10-31 2002-01-08 イーライ・リリー・アンド・カンパニー 抗血栓性ジアミン
PT791591E (pt) * 1996-02-22 2001-12-28 Lilly Co Eli Benzotiofenos, formulacoes que os contem e metodos
SK281737B6 (sk) 1996-04-19 2001-07-10 American Home Products Corporation 2-fenylindolové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
CA2214070C (en) 1996-08-29 2006-03-14 Eli Lilly And Company Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
ID19392A (id) 1996-08-29 1998-07-09 Lilly Co Eli Senyawa naftil dan bahan pertengahan serta komposisi dan metode penggunaan
CA2213810C (en) 1996-08-29 2006-06-06 Lewis Dale Pennington Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
CA2213814A1 (en) 1996-08-29 1998-02-28 Henry Uhlman Bryant Naphthalene compounds, intermediates, formulations, and methods
CA2217810A1 (en) * 1996-10-10 1998-04-10 Eli Lilly And Company 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods
JPH10204082A (ja) 1996-10-25 1998-08-04 Eli Lilly & Co 選択的エストロゲンレセプターモジュレーターとしての活性を有する置換されたベンゾ[b]チオフェン化合物
PL374845A1 (en) * 2002-07-22 2005-11-14 Eli Lilly And Company Selective estrogen receptor modulators containing a phenylsulfonyl group

Similar Documents

Publication Publication Date Title
JP2007510619A5 (enExample)
JP2007522220A5 (enExample)
JP2009535462A5 (enExample)
JP2005518413A5 (enExample)
JP2006526031A5 (enExample)
JP2006515626A5 (enExample)
JP2009545527A5 (enExample)
JP2010523692A5 (enExample)
JP2010536766A5 (enExample)
JP2010511721A5 (enExample)
JP2005511547A5 (enExample)
JP2007511546A5 (enExample)
JP2005053931A5 (enExample)
JP2009519226A5 (enExample)
JP2009501198A5 (enExample)
JP2008044952A5 (enExample)
JP2005523922A5 (enExample)
JP2010501474A5 (enExample)
JP2005502635A5 (enExample)
CA2490580A1 (en) Selective estrogen receptor modulators containing a naphthalene group
JP2010520851A5 (enExample)
JP2007519618A5 (enExample)
JP2005524632A5 (enExample)
JP2010507590A5 (enExample)
JP2008513510A5 (enExample)